PMID: 2105921Feb 1, 1990Paper

Bowel complications after radiotherapy for carcinoma of the prostate: the volume effect

International Journal of Radiation Oncology, Biology, Physics
H MameghanA Tynan

Abstract

Late radiation-induced bowel complications were studied in 218 patients treated for localized carcinoma of the prostate by radical radiotherapy at the Prince of Wales Hospital between 1980 and 1986. Mild to moderate toxicity was seen in 38 cases, and severe toxicity requiring surgery occurred in 3 patients. The total actuarial complication rate (by 5 years) for all grades was 24% and for severe complications was 1.8%. Significant patient-related risk factors were older age at the time of radiotherapy (p = 0.035) and a previous history of abdominal operations (p = 0.028). Among treatment-related risk factors only inclusion of the whole pelvis in the irradiated volume had a significant association with this complication (p = 0.015). The risk of bowel complications was not related to the total radiation dose or to the use of interstitial implants as employed in this series.

References

Jul 1, 1979·International Journal of Radiation Oncology, Biology, Physics·M A El SenoussiB C Borlase
Sep 1, 1986·Journal of Surgical Oncology·K Leonard, J A Stryker
Oct 1, 1981·International Journal of Radiation Oncology, Biology, Physics·M V PilepichF R Zivnuska

❮ Previous
Next ❯

Citations

Jan 1, 1995·Seminars in Surgical Oncology·D P Dearnaley
Apr 1, 1996·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·G Borghede, M Sullivan
Sep 1, 1994·Diseases of the Colon and Rectum·E H BirnbaumJ W Fleshman
May 15, 1995·International Journal of Radiation Oncology, Biology, Physics·F CampostriniE Donati
Jul 30, 1995·International Journal of Radiation Oncology, Biology, Physics·Z X LiaoS L Tucker
Jan 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D KardamakisK M de Bruijn
Nov 11, 2003·Critical Reviews in Oncology/hematology·Sergio VillaPatrizia Olmi
Apr 7, 2004·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Asa KarlsdóttirOlav Dahl
Jan 1, 1994·Seminars in Roentgenology·R A DuBrow
Jun 19, 2001·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·P C O'Brien
Jul 27, 2002·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Per FranssonAnders Widmark
Jul 17, 2003·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Oliver KoelblMichael Flentje
May 1, 1997·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·G Borghede, H Hedelin
Jul 1, 1999·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·J W DenhamS Wright
Feb 15, 2001·International Journal of Radiation Oncology, Biology, Physics·A JacksonC C Ling
Sep 25, 2001·International Journal of Radiation Oncology, Biology, Physics·C CapirciG Mandoliti
Jan 1, 1997·International Journal of Radiation Oncology, Biology, Physics·L T YonemotoJ M Slater
Mar 1, 1997·International Journal of Radiation Oncology, Biology, Physics·J KatcherJ W Sohn
Jul 4, 1998·International Journal of Radiation Oncology, Biology, Physics·R C MillerJ E Krook
Jun 1, 1994·The Australian and New Zealand Journal of Surgery·H MameghanS Brook
Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·L B Marks, M S Anscher
Jan 15, 1993·International Journal of Radiation Oncology, Biology, Physics·S VijayakumarG T Chen
Apr 25, 2006·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Piet DirixHendrik Van Poppel
Nov 8, 2005·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·David ChristieDana Bill
Feb 1, 1997·The Surgical Clinics of North America·T J Saclarides
Aug 24, 2011·Radiation Research·Dan JiaPeter M Corry
May 26, 2009·International Journal of Radiation Oncology, Biology, Physics·Ayal A AizerRichard E Peschel
Sep 1, 1991·International Journal of Radiation Oncology, Biology, Physics·T PicklesG B Goodman
Apr 25, 2000·Journal of Gerontological Nursing·M PickettV Burggraf
Oct 20, 1999·The Australian and New Zealand Journal of Surgery·J P GerardC Ginestet
Oct 20, 1999·The Australian and New Zealand Journal of Surgery·P G Yuile
Jan 1, 1995·Acta Oncologica·T K JoensuuM J Kajanti
Feb 7, 2014·Radiation Oncology Journal·Ji Hyeon JooSeung Do Ahn
Feb 18, 2011·Current Opinion in Supportive and Palliative Care·Linda J Wedlake, H Jervoise N Andreyev
May 1, 1996·Australasian Radiology·C I Franklin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.